Free Trial

Diploma (LON:DPLM) Stock Price Crosses Above 200 Day Moving Average - Here's What Happened

Diploma logo with Industrials background

Diploma PLC (LON:DPLM - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 4,316.49 ($58.93) and traded as high as GBX 4,854 ($66.27). Diploma shares last traded at GBX 4,829.90 ($65.94), with a volume of 254,417 shares traded.

Diploma Stock Performance

The firm has a market capitalization of £6.51 billion, a price-to-earnings ratio of 56.07, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The firm's 50-day moving average price is GBX 4,524.23 and its two-hundred day moving average price is GBX 4,319.74. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17.

Diploma (LON:DPLM - Get Free Report) last released its quarterly earnings data on Wednesday, May 21st. The company reported GBX 80.20 ($1.09) earnings per share for the quarter. Diploma had a return on equity of 13.18% and a net margin of 9.25%. Sell-side analysts predict that Diploma PLC will post 163.7995512 earnings per share for the current year.

Insider Buying and Selling at Diploma

In other news, insider Katie Bickerstaffe purchased 44 shares of the business's stock in a transaction that occurred on Wednesday, May 21st. The stock was purchased at an average cost of GBX 4,867 ($66.44) per share, with a total value of £2,141.48 ($2,923.52). Over the last 90 days, insiders have bought 96 shares of company stock valued at $473,173. 0.52% of the stock is currently owned by corporate insiders.

Diploma Company Profile

(Get Free Report)

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.

Featured Articles

Should You Invest $1,000 in Diploma Right Now?

Before you consider Diploma, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.

While Diploma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines